• Outset Medical Inc OM.OQ reported a quarterly adjusted loss of 37 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -59 cents. The mean expectation of five analysts for the quarter was for a loss of 41 cents per share. Wall Street expected results to range from -43 cents to -40 cents per share.

• Revenue fell 3.4% to $29.47 million from a year ago; analysts expected $28.47 million.

• Outset Medical Inc's reported EPS for the quarter was a loss of 49 cents​.

• The company reported a quarterly loss of $25.64 million.

• Outset Medical Inc shares had fallen by 18.2% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 2.3% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Outset Medical Inc is $3.00

This summary was machine generated from LSEG data February 19 at 10:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)